Caerulomycin A structure
|
Common Name | Caerulomycin A | ||
---|---|---|---|---|
CAS Number | 21802-37-9 | Molecular Weight | 229.23500 | |
Density | 1.23g/cm3 | Boiling Point | 400.4ºC at 760mmHg | |
Molecular Formula | C12H11N3O2 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 195.9ºC | |
Symbol |
GHS06 |
Signal Word | Danger |
Use of Caerulomycin ACaerulomycin A (Cerulomycin; Caerulomycin), an antifungal compound, induces generation of T cells, enhances TGF-β-Smad3 protein signaling via suppressing interferon-γ-induced STAT1 signaling. Antifungal and antibiotic activity, and used in autoimmune diseases[1]. |
Name | caerulomycin A |
---|---|
Synonym | More Synonyms |
Description | Caerulomycin A (Cerulomycin; Caerulomycin), an antifungal compound, induces generation of T cells, enhances TGF-β-Smad3 protein signaling via suppressing interferon-γ-induced STAT1 signaling. Antifungal and antibiotic activity, and used in autoimmune diseases[1]. |
---|---|
Related Catalog | |
Target |
Antifungal[1] TGF-β-Smad3[1] |
References |
Density | 1.23g/cm3 |
---|---|
Boiling Point | 400.4ºC at 760mmHg |
Molecular Formula | C12H11N3O2 |
Molecular Weight | 229.23500 |
Flash Point | 195.9ºC |
Exact Mass | 229.08500 |
PSA | 67.60000 |
LogP | 1.96030 |
Storage condition | 2-8℃ |
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301-H315-H319 |
Precautionary Statements | P301 + P310-P305 + P351 + P338 |
RIDADR | UN 2811 6.1 / PGIII |
HS Code | 2933399090 |
Precursor 8 | |
---|---|
DownStream 1 | |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
[Development of a genetic modification system for caerulomycin producer Actinoalloteichus sp. WH1-2216-6].
Wei Sheng Wu Xue Bao 51(8) , 1032-41, (2011) In order to enable the caerulomyicn biosynthetic study by in vivo gene disruptions, it is crucial to develop a genetic modification system for the producer Actinoalloteichus sp. WH1-2216-6.The spore g... |
|
Total synthesis of caerulomycin C via the halogen dance reaction.
Org. Lett. 4(14) , 2385-8, (2002) [reaction: see text] The total synthesis of caerulomycin C is described. Key steps in this synthesis utilize 1,2-, 1,3-, and 1,4-halogen dance reactions for the functionalization of the pyridine ring. |
|
Caerulomycin, an antifungal antibiotic with marked in vitro and in vivo activity against Entamoeba histolytica.
Z. Parasitenkd. 70(5) , 569-73, (1984) The anti-amoebic action of the bipyridyl antibiotic caerulomycin was assessed in vitro and in vivo using various strains of Entamoeba histolytica from polyxenic, axenic and monoxenic cultures. Minimum... |
CERULOMYCIN |
(E)-4-methoxy-2,2'-bipyridyl-6-aldoxime |
CAERULOMYCIN A |
4-Methoxy-2,2'-bipyridine-6-carbaldehyde (E)-oxime |
4-Methoxy-[2,2']bipyridyl-6-carbaldehyd-(E)-oxim |
Caerulomycin,Cerulomycin |
(2,2'-Bipyridine)-6-carboxaldehyde,4-methoxy-,oxime,(E) |
(E)-4-Methoxy-[2,2'-bipyridine]-6-carbaldehyde oxime |
4-methoxy-[2,2']bipyridinyl-6-carbaldehyde oxime |
4-methoxy-[2,2']bipyridyl-6-carbaldehyde-(E)-oxime |
Caerulomycin A |
CAERULOMYCIN |